| Literature DB >> 15580219 |
Thomas J A Lehman1, Sharon J Schechter, Robert P Sundel, Sheila K Oliveira, Anna Huttenlocher, Karen B Onel.
Abstract
Thirteen children with difficult systemic onset juvenile rheumatoid arthritis were treated with thalidomide. At 6 months, 11 of the 13 were able to reduce their use of prednisone ( P < .002), with a concurrent improvement in erythrocyte sedimentation rate ( P < .0001) and an increase in hemoglobin level ( P < 0.005). Juvenile rheumatoid arthritis improvement scores >/=50% were obtained by 10 of the 13 children.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15580219 DOI： 10.1016/j.jpeds.2004.08.020
Source DB: PubMed Journal: J Pediatr ISSN： 0022-3476 Impact factor: 4.406